ROS Pleiotropy in Melanoma and Local Therapy with Physical Modalities

Sanjeev Kumar Sagwal1, Sander Bekeschus1

  • 1ZIK Plasmatis, Leibniz Institute for Plasma Science and Technology (INP), Felix-Hausdorff-Str. 2, 17489 Greifswald, Germany.

Insights

Reactive oxygen species (ROS) are key to melanoma development and treatment. Understanding ROS roles in cell signaling and physical therapies offers new avenues for combating this deadly skin cancer.

Area of Science:

  • Biochemistry
  • Oncology
  • Dermatology

Background:

  • Metabolic processes generate reactive oxygen species (ROS), which cause oxidative damage linked to aging and diseases like cancer.
  • ROS were once viewed as harmful byproducts but are now recognized for their roles in cell signaling and cancer therapy.
  • Melanoma, a deadly skin cancer, is influenced by ROS, necessitating a deeper understanding of their complex roles.

Purpose of the Study:

  • To review the types, sources, and pathways of ROS in melanoma.
  • To explore the dual roles of ROS in antioxidant/oxidant regulation, hypoxia, metabolism, and cell death.
  • To discuss the implications of ROS in physical therapy modalities for melanoma treatment.

Main Methods:

  • Literature review of ROS in melanoma.
  • Analysis of ROS involvement in cellular processes (antioxidant regulation, hypoxia, metabolism, cell death).
  • Examination of ROS in physical therapies including radiotherapy, electrochemotherapy, hyperthermia, photodynamic therapy, and medical gas plasma.

Main Results:

  • ROS play multifaceted roles in melanoma, influencing cell survival and death.
  • ROS are integral to the efficacy of various physical therapy modalities used against melanoma.
  • Understanding ROS mechanisms can illuminate strategies to overcome therapy resistance in melanoma.

Conclusions:

  • ROS are critical players in melanoma biology and therapeutic responses.
  • Targeting ROS pathways presents a promising strategy for enhancing melanoma treatment outcomes.
  • Further research into ROS is essential for developing more effective therapies against melanoma and overcoming resistance.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
726
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K